"Medical Center South, part of UofL Health, opened in 2006 to provide outpatient and emergency care, along with specialty physician services to fast-growing Bullitt County. The medical center offers a full range of services, including 24/7 emergency care, chest pain observation services, outpatient surgery, digital mammography, diagnostic and medical imaging, physician care, rehab services and more."

During the past decade, Jewish Hospital Medical Center South conducted 111 clinical trials. In the 10-year time frame, 111 clinical trials started and 42 clinical trials were completed, i.e. on average, 37.8% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 33 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jewish Hospital Medical Center South" #1 sponsor was "National Cancer Institute (NCI)" with 71 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 16 trials sponsored and "NRG Oncology" with 16 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jewish Hospital Medical Center South" #1 collaborator was "National Cancer Institute (NCI)" with 76 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Agenus Inc." with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Jewish Hospital Medical Center South" are "Recurrent Ovarian Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (6 trials). Many other conditions were trialed in "Jewish Hospital Medical Center South" in a lesser frequency.

Most popular intervention types in "Jewish Hospital Medical Center South" are "Drug" (116 trials), "Other" (89 trials), "Biological" (68 trials), "Procedure" (42 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (44 trials), "Quality-of-Life Assessment" (35 trials), "Computed Tomography" (25 trials), "Nivolumab" (24 trials) and "Questionnaire Administration" (24 trials). Other intervention names were less common.

The vast majority of trials in "Jewish Hospital Medical Center South" are 121 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Jewish Hospital Medical Center South". undefined are not yet recruiting, 53 are recruiting, 70 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Jewish Hospital Medical Center South, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Jewish Hospital Medical Center South, 3 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".